Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Endometrial Neoplasms × apatinib × Clear all

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Stomach Neoplasms 28 Carcinoma, Hepatocellular 18 Small Cell Lung Carcinoma 14 Sarcoma 12 Carcinoma, Non-Small-Cell Lung 12 Ovarian Neoplasms 11 Colorectal Neoplasms 11 Breast Neoplasms 10 Nasopharyngeal Carcinoma 9 Esophageal Squamous Cell Carcinoma 9 Triple Negative Breast Neoplasms 8 Cholangiocarcinoma 8 Squamous Cell Carcinoma of Head and Neck 6 Head and Neck Neoplasms 5 Esophageal Neoplasms 5 Biliary Tract Neoplasms 5 Melanoma 4 Lung Neoplasms 4 Uterine Cervical Neoplasms 3 Thyroid Neoplasms 3 Solid Tumor 3 Recurrence 3 Pancreatic Neoplasms 3 Osteosarcoma 3 Neoplasm Metastasis 3 Liver Neoplasms 3 Glioma 3 Carcinoma, Adenoid Cystic 3 Neoplasms 2 Nasopharyngeal Neoplasms 2

Interventions

Paclitaxel 31 Carboplatin 23 pembrolizumab 17 Bevacizumab 14 Letrozole 13 Cisplatin 9 Megestrol Acetate 8 dostarlimab 7 olaparib 6 lenvatinib 6 abemaciclib 6 Metformin 6 Radiotherapy 5 Gemcitabine 5 Everolimus 5 rucaparib 4 niraparib 4 durvalumab 4 Specimen Handling 4 Nivolumab 4 Medroxyprogesterone Acetate 4 Fulvestrant 4 Fluorouracil 4 Doxorubicin 4 Docetaxel 4 temsirolimus 3 ridaforolimus 3 mirvetuximab soravtansine 3 avelumab 3 Taxes 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06771154 2025-01-13

A-CAPE

Peking Union Medical College Hospital

Phase 2 Not yet recruiting

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡